1254934

BioReliance Corporation — FEI 1122041

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Rockville, MD (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures